U.S. Physical Therapy, Inc. Forecasted to Earn FY2025 Earnings of $2.50 Per Share (NYSE:USPH)

U.S. Physical Therapy, Inc. (NYSE:USPH) – Analysts at Barrington Research cut their FY2025 earnings per share (EPS) estimates for shares of U.S. Physical Therapy in a research note issued on Wednesday, October 9th. Barrington Research analyst M. Petusky now expects that the company will post earnings of $2.50 per share for the year, down from their prior forecast of $2.85. Barrington Research has a “Outperform” rating and a $108.00 price objective on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.47 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s FY2026 earnings at $2.85 EPS.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The company had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. During the same period last year, the business earned $0.76 earnings per share. The company’s quarterly revenue was up 10.4% on a year-over-year basis.

Several other equities research analysts also recently weighed in on the company. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Bank of America reiterated a “neutral” rating and set a $90.00 price target (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday.

U.S. Physical Therapy Stock Down 0.9 %

U.S. Physical Therapy stock opened at $77.52 on Friday. The stock has a 50-day simple moving average of $84.38 and a 200-day simple moving average of $94.61. The company has a market capitalization of $1.17 billion, a P/E ratio of 73.13, a PEG ratio of 3.16 and a beta of 1.39. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. U.S. Physical Therapy has a fifty-two week low of $76.18 and a fifty-two week high of $113.63.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Silvercrest Asset Management Group LLC acquired a new stake in U.S. Physical Therapy during the first quarter worth approximately $8,158,000. Renaissance Technologies LLC increased its stake in U.S. Physical Therapy by 763.7% in the second quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock valued at $6,425,000 after purchasing an additional 61,474 shares during the last quarter. Norden Group LLC lifted its position in U.S. Physical Therapy by 1,841.6% during the first quarter. Norden Group LLC now owns 63,938 shares of the company’s stock worth $7,217,000 after buying an additional 60,645 shares during the period. Vanguard Group Inc. boosted its stake in U.S. Physical Therapy by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 1,062,427 shares of the company’s stock worth $98,954,000 after buying an additional 26,224 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in U.S. Physical Therapy by 2.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after buying an additional 10,462 shares during the period.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the transaction, the chief operating officer now directly owns 7,038 shares in the company, valued at $580,635. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. In related news, Director Kathleen A. Gilmartin purchased 2,000 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the purchase, the director now directly owns 18,904 shares in the company, valued at $1,627,445.36. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares of the company’s stock, valued at $580,635. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were paid a $0.44 dividend. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.76 annualized dividend and a dividend yield of 2.27%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 166.04%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.